文献速递肺栓塞与肺血管病

急性症状性肺栓塞合并上肢与下肢深静脉血栓的临床表现与预后比较

Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis.
PubMed 文献 · Thorax · 2025-05-20

上肢深静脉血栓组更年轻、合并癌症更多,但肺栓塞严重程度临床征象更少。上肢深静脉血栓与30天和90天全因死亡率升高独立相关,短期预后更差。

要点

  • 合并上肢深静脉血栓的肺栓塞患者30天死亡率7.3%,高于下肢深静脉血栓组的3.5%。
  • 上肢深静脉血栓组30天全因死亡风险调整后HR 1.49(95%CI 1.04–2.13)。
  • 尽管上肢深静脉血栓组肺栓塞严重程度临床征象更少,短期预后反而更差。

核心结论

  • 合并上肢深静脉血栓的急性症状性肺栓塞患者短期预后更差,全因死亡率更高。
  • 该组患者肺栓塞严重程度临床征象更少,提示未识别的患者特征可能影响预后。

研究设计与样本

  • 采用Cox回归分析,标准化差异(SRD)用于报告临床特征以减少I类错误膨胀。

主要发现

  • 上肢深静脉血栓组患者更年轻(SRD 0.231),更常合并癌症(SRD 0.395)或非中央型肺栓塞(SRD 0.445)。
  • 上肢深静脉血栓组较少出现肌钙蛋白升高(SRD 0.376)或右心室功能障碍(SRD 0.249)。
  • 30天死亡率上肢深静脉血栓组7.3% vs 下肢深静脉血栓组3.5%(p<0.001),90天死亡率14% vs 6.0%。
  • 上肢深静脉血栓组30天和90天肺栓塞相关死亡、静脉血栓栓塞复发及大出血发生率均增加。
  • 多水平多变量分析显示上肢深静脉血栓与30天(aHR 1.49;95%CI 1.04–2.13)和90天(aHR 1.52;95%CI 1.15–2.00)全因死亡风险升高相关。

临床怎么用

  • 对急性症状性肺栓塞合并上肢深静脉血栓的患者应警惕短期死亡风险升高。
  • 即使肺栓塞严重程度临床征象较少,合并上肢深静脉血栓仍提示预后可能较差。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of deep vein thrombosis (DVT) location on acute pulmonary embolism (PE) prognosis remains uncertain. METHODS: Using the Registro Informatizado de Enfermedad TromboEmbólica registry, we assessed 30-day and 90-day outcomes in patients with acute symptomatic PE and concomitant upper-extremity (UEDVT) versus lower-extremity DVT (LEDVT). Cox regression was employed for analysis, and standardised differences (SRD) were used for reporting clinical characteristics to minimise type I error overinflation. The primary outcome was 30-day all-cause mortality, with secondary outcomes including 90-day mortality, fatal PE, venous thromboembolism (VTE) recurrences, and major bleeding. RESULTS: Among 21 617 patients with PE (March 2001-April 2023), 508 had UEDVT, and 21 109 had LEDVT. Patients with UEDVT were younger (SRD: 0.231), more often had cancer (SRD: 0.395) or non-central PEs (SRD: 0.445), but less frequently had raised troponin levels (SRD: 0.376) or right ventricle dysfunction (SRD: 0.249). Thirty-day mortality was higher in UEDVT compared with LEDVT (7.3% vs 3.5%; p<0.001), with similar trends at 90 days (14% vs 6.0%) and in subgroup analysis in patients without cancer. Increased rates of PE-related mortality, VTE recurrences and major bleeding were noted in patients with UEDVT at both 30 and 90 days. UEDVT was associated with a higher risk for 30-day (adjusted HR (aHR): 1.49; 95% CI 1.04 to 2.13) and 90-day (aHR: 1.52; 95% CI 1.15 to 2.00) all-cause mortality on multilevel multivariable analysis. CONCLUSIONS: Patients with concomitant UEDVT experienced worse short-term outcomes, including higher mortality, despite fewer clinical signs of PE severity compared with LEDVT. These findings suggest that unrecognised patient characteristics might influence prognosis, warranting further research.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Dubois-Silva, Bikdeli, Jiménez, et al. Clinical presentation and prognosis of acute symptomatic pulmonary embolism in patients with concomitant upper-extremity versus lower-extremity deep vein thrombosis. Thorax. 2025. PMID: 40081905. doi:10.1136/thorax-2024-221960

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。